Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.
Sandanayake NS, Sinclair J, Andreola F, Chapman MH, Xue A, Webster GJ, Clarkson A, Gill A, Norton ID, Smith RC, Timms JF, Pereira SP. Sandanayake NS, et al. Among authors: clarkson a. Br J Cancer. 2011 Oct 25;105(9):1370-8. doi: 10.1038/bjc.2011.376. Epub 2011 Oct 4. Br J Cancer. 2011. PMID: 21970875 Free PMC article.
Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.
Bullock M, O'Neill C, Chou A, Clarkson A, Dodds T, Toon C, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Learoyd DL, Capper D, von Deimling A, Clifton-Bligh RJ, Gill AJ. Bullock M, et al. Among authors: clarkson a. Endocr Relat Cancer. 2012 Nov 9;19(6):779-84. doi: 10.1530/ERC-12-0239. Print 2012 Dec. Endocr Relat Cancer. 2012. PMID: 22997209
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.
Cooper WA, Yu B, Yip PY, Ng CC, Lum T, Farzin M, Trent RJ, Mercorella B, Clarkson A, Kohonen-Corish MR, Horvath LG, Kench JG, McCaughan B, Gill AJ, O'Toole SA. Cooper WA, et al. Among authors: clarkson a. J Clin Pathol. 2013 Sep;66(9):744-8. doi: 10.1136/jclinpath-2013-201607. Epub 2013 Jun 11. J Clin Pathol. 2013. PMID: 23757037
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Aksoy YA, Xu B, Viswanathan K, Ahadi MS, Al Ghuzlan A, Alzumaili B, Bani MA, Barletta JA, Chau N, Chou A, Clarkson A, Clifton-Bligh RJ, De Leo A, Dogan S, Ganly I, Ghossein R, Gild ML, Glover AR, Hadoux J, Lamartina L, Lubin DJ, Magliocca K, Najdawi F, Nigam A, Papachristos A, Repaci A, Robinson BG, Sheen A, Shi Q, Sidhu SB, Sioson L, Solaroli E, Sywak MS, Tallini G, Tsang V, Turchini J, Untch BR, Gill AJ, Fuchs TL. Aksoy YA, et al. Among authors: clarkson a. Histopathology. 2024 May;84(6):947-959. doi: 10.1111/his.15141. Epub 2024 Jan 22. Histopathology. 2024. PMID: 38253940
Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI).
Liu J, van Beusekom H, Bu XL, Chen G, Henrique Rosado de Castro P, Chen X, Chen X, Clarkson AN, Farr TD, Fu Y, Jia J, Jolkkonen J, Kim WS, Korhonen P, Li S, Liang Y, Liu GH, Liu G, Liu YH, Malm T, Mao X, Oliveira JM, Modo MM, Ramos-Cabrer P, Ruscher K, Song W, Wang J, Wang X, Wang Y, Wu H, Xiong L, Yang Y, Ye K, Yu JT, Zhou XF, Zille M, Masters CL, Walczak P, Boltze J, Ji X, Wang YJ. Liu J, et al. Among authors: clarkson an. Neuroprotection. 2023 Dec;1(2):84-98. doi: 10.1002/nep3.23. Epub 2023 Sep 21. Neuroprotection. 2023. PMID: 38223913 Free article.
407 results